s6y
Company name or ticker
Search
Aimmune Therapeutics, Inc.
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Filed
Tuesday, October 13, 2020
Accession number
0001193125-20-268640
Documents
POS AM
POS AM
On sec.gov
Filing index
All files
Complete submission text
SGML header